EP2370176A2 - Hair treatment agents comprising imidazolines and diesters of ethylene glycol - Google Patents

Abstract

The invention relates to hair treatment agents, which contain at least one quaternary imidazoline derivative having at least two long fatty groups according to the formula (I) and at least one diester of ethylene glycol having two long fatty groups according to the formula (II) and a cosmetic carrier, wherein the hair treatment agents cause surprisingly good properties of the treated skin and hair, in particular improved combability, improved shininess, and improved elasticity.

Description

 "Hair treatment agents with imidazolines and diesters of ethylene glycol"

The invention relates to hair treatment compositions containing cationic imidazolines and diesters of

Ethylene glycols and the use of these agents for the treatment of skin and hair.

Not least by the heavy use of the hair, for example by dyeing or

Perms as well as by the hair with shampoo and by environmental pollution, the importance of care products with long-lasting effect as possible.

The available active ingredients generally preferably act on the hair surface. However, the known active ingredients can not cover all needs sufficiently. There is therefore still a need for active ingredients or combinations of active ingredients for cosmetic

Agent with good care properties and good biodegradability. Especially in dye- and / or electrolyte-containing formulations there is a need for additional caring

Active ingredients that can be easily incorporated into known formulations.

Quaternary ammonium compounds of the mono-, di- and / or trialkylammonium type have been known for a long time. A disadvantage of these compounds, however, is their lack of biological

Degradability. Therefore, cationic compounds containing at least one ester group, the so-called ester quats, have been developed. These, however, have a feeling of being unpleasantly dull as regards the feel and feel of wet skin and hair and the touch and feel of the skin or hair which has been rewashed after washing, which is also known as

"Squeaky" audible.

However, it has now been found, completely surprisingly, that a combination of active ingredients of at least one derivative of the imidazolines and at least one diester of ethylene glycol achieved very particularly advantageous results.

When using this combination, there are surprisingly good properties of the treated

Skin and hair, in particular to improved combing, improved gloss and improved elasticity as well as a significantly increased wash resistance dyed

Hair, as well as to a longer durability with a simultaneous better forming performance at

Well processes such as water wave and perm.

A first object of the present invention is therefore a hair treatment composition containing a) at least one quaternary imidazoline derivative having at least two long fat residues according to the formula I and

Formula I, in the

- The radicals R1 and R2 are each independently a saturated or unsaturated, linear or branched hydrocarbon radical having 8 to 30 carbon atoms, and

- X ^'is anion from the group consisting of methosulfate, chloride, fluoride, bromide or the phosphates, b) at least one diester of ethylene glycol having two long fatty residues according to the formula II

Formula II, in which the radicals R3 and R4 are each independently a saturated or unsaturated, linear or branched hydrocarbon radical having 8 to 30

Carbon atoms, and c) a cosmetic carrier.

Hair treatment compositions for the purposes of the present invention are, for example, hair dyes, bleaching agents, hair shampoos, hair conditioners, conditioning shampoos, hair sprays, hair rinses, hair treatments, hair wraps, hair tonics, perming solutions, hair dye shampoos, hair dyes, hair fixatives, hair dressings, hair styling preparations, hair lotions , Mousse, hair gels, hair waxes or combinations thereof. Preferred agents according to the invention are shampoos, conditioners or hair tonics.

By combing is understood according to the invention both the combability of the wet fiber, as well as the combability of the dry fiber. As a measure of the combing used the combing work or the force used during the combing process of a fiber collective. The measurement parameters can be assessed by the skilled person or quantified by measuring devices. The grip defines the tactility of a fiber collective, whereby the expert sensoryly senses and evaluates the parameters fullness and suppleness of the collective.

According to the invention, cosmetic creams, emulsions, gels or surfactant-containing foaming solutions, for example shampoos, foam aerosols or other preparations which are particularly suitable for use on the hair, are particularly suitable as cosmetic carriers. But it is also conceivable to integrate the ingredients in a powdered or tablet-like formulation, which is dissolved in water before use. The cosmetic carriers may in particular be aqueous or aqueous-alcoholic. An aqueous cosmetic carrier contains at least 50% by weight of water.

Aqueous-alcoholic cosmetic carriers aqueous solutions in the context of the present invention comprising 3 to 70 wt .-% of a C _r C ₆ alcohol, especially methanol, ethanol or propanol, isopropanol, butanol, isobutanol, tert-butanol, n -Pentanol, iso-pentanols, n-hexanol, isohexanols, glycol, glycerol, 1, 2-pentanediol, 1, 5-pentanediol, 1, 2-hexanediol or 1, 6-hexanediol to understand. The compositions of the invention may additionally contain other organic solvents, such as methoxybutanol, benzyl alcohol, ethyl diglycol or 1, 2-propylene glycol. Preference is given to all water-soluble organic solvents.

As ingredient a) the agents according to the invention contain at least one quaternary imidazoline compound, i. a compound having a positively charged imidazoline ring. The formula I shown below shows the structure of these compounds.

Formula I

The radicals R1 and R2 are each independently a saturated or unsaturated, linear or branched hydrocarbon radical having a chain length of 8 to 30 carbon atoms. In preferred compounds of the formula I, the radicals R 1 and R 2 are identical. Preferred compounds of the formula I contain straight-chain alkyl radicals and can be described by the formula Ia:

Ia

In preferred compounds of the formula Ia, n is 11, 15, 17, 19 or 20 and X is

Methosulfate.

In a particularly preferred compound of the formula I, R 1 and R _{2 are} - (CH ₂ J ₂₀ CH ₃ .

Hair treatment preparations, characterized in that they contain at least one quaternary

Imidazoline derivative of the formula I, in which both radicals R 1 and R _{2 are} the radical - (CH ₂ J ₂₀ CH ₃ and X ^" means methosulfate, are preferred according to the invention.

A commercial product of this chain length is known, for example, under the name Quaternium-91.

The imidazolines of the formula I are preferably in the compositions according to the invention in

Amounts from 0.01 to 20 wt.%, Preferably in amounts of 0.05 to 10 wt.% And most preferably in amounts of 0.1 to 7.5 wt.% Contain. The very best results are included

Quantities of 0.1 to 5 wt.% In each case based on the total composition of the respective

Received by means. Preferred hair treatment compositions according to the invention contain - based on her

Weight - 0.1 to 5 wt .-%, preferably 0.25 to 4 wt .-%, more preferably 0.5 to 3 wt .-% and in particular 0.75 to 2 wt .-% quaternary (s) Imidazolinderivat (e) with at least two long ones

Fat residues according to formula I.

As ingredient b), the compositions according to the invention contain at least one diester of ethylene glycol with two long fatty residues. Particularly preferred compounds of the formula II can be characterized by

Describe Formula IIa

where k and m independently represent values from 7 to 29. In particularly preferred compounds of the formula IIa, k = m, very particular preference k and m are each the values n, 13, 15, 17 or 19. Particularly preferred hair treatment _{compositions according to the} invention are characterized in that they contain at least one diester of ethylene glycol with two long fatty radicals of the formula II, in which both radicals R3 and R4 are the radical - (CH ₂ ) _I7 CH ₃ .

The diesters of ethylene glycol having two long fatty radicals of the formula II are preferably present in the compositions according to the invention in amounts of from 0.01 to 20% by weight, preferably in amounts of from 0.05 to 10% by weight and very particularly preferably in amounts of 0, 1 to 7.5% by weight. The very best results are obtained with amounts of from 0.1 to 5% by weight, based in each case on the total composition of the particular agent. Preferred hair treatment compositions according to the invention contain - based on their weight - 0.1 to 5 wt .-%, preferably 0.25 to 4 wt .-%, more preferably 0.5 to 3 wt .-% and in particular 0.75 to 2 wt % Diester of ethylene glycol with two long fat residues of formula II.

The agents according to the invention contain an active ingredient combination of at least two constituents, the constituents a) and b) preferably being used within a specific weight ratio to one another. In preferred agents according to the invention, the weight ratio of imidazoline derivatives of the formula I to diesters of the ethylene glycol of the formula II is 20: 1 to 1:20, more preferably 10: 1 to 1:10, particularly preferably 5: 1 to 1: 5 and in particular 2.5 : 1 to 1: 2.5.

The agents according to the invention may contain further active ingredients and adjuvants. These are described below.

The agents according to the invention preferably additionally comprise at least one emulsifier or a surfactant, surface-active substances being referred to as surfactants or as emulsifiers, depending on the field of use, and selected from anionic, cationic, zwitterionic, ampholytic and nonionic surfactants and emulsifiers.

According to the invention preferred hair treatment compositions are characterized in that they - based on its weight - 0.5 to 70 wt .-%, preferably 1 to 60 wt .-% and in particular 5 to 25 wt .-% of anionic (s) and / or nonionic (s) and / or cationic and / or amphoteric surfactant (s).

Suitable anionic surfactants and emulsifiers for the compositions according to the invention are all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. As a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group having about 8 to 30 carbon atoms. In addition, glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups may be present in the molecule. Examples of suitable anionic surfactants and emulsifiers are, in each case in the form of the sodium, potassium and ammonium as well as the mono-, di- and trialkanolammonium salts having 2 to 4 C atoms in the alkanol group, linear and branched fatty acids with 8 to 30 carbon atoms (soaps),

Ethercarbonsäuren the formula RO- (CH ₂ -CH ₂ O) _x -CH ₂ -COOH, in which R is a linear alkyl group having 8 to 30 carbon atoms and x = O or 1 to 16, acylsarcosides having 8 to 24 C Atoms in the acyl group, acyltaurides having 8 to 24 carbon atoms in the acyl group, acyl isethionates having 8 to 24 carbon atoms in the acyl group, linear alkanesulfonates having 8 to 24 carbon atoms, linear alpha-olefin sulfonates having 8 to 24 carbon atoms , Alpha-sulfofatty acid methyl esters of fatty acids having 8 to 30 carbon atoms, acylglutamates, in particular sodium N-cocoyl and sodium N-stearoyl-L-glutamate, esters of a hydroxy-substituted di- or tricarboxylic acid of the general formula (II),

X

I HO - C - COOR ¹ (II)

I

Y is --CH - COOR ² wherein X is H or a -CH ₂ COOR group, Y is H or -OH is under the condition that Y is H when X is -CH ₂ COOR, R, R ¹ and R ² independently of one another denote a hydrogen atom, an alkali metal or alkaline earth metal cation, an ammonium group, the cation of an ammonium organic base or a radical Z derived from a polyhydroxylated organic compound selected from the group of etherified (C ₆ -C ₈ ) Alkyl polysaccharides having 1 to 6 monomeric saccharide units and / or the etherified aliphatic (C ₆ -C ₆ ) hydroxyalkylpolyols having 2 to 16 hydroxyl radicals are selected, provided that at least one of the groups R, R ¹ or R ^{2 is} one Rest Z is,

Esters of sulfosuccinic acid or sulfosuccinates of general formula (III),

H ₂ C - COOR ¹ (III)

I

_M (n ₊ / n) -Q ₃₈ _Q _H _ COOR ² in the M ^{(n + / n)} for n = 1 a hydrogen atom, an alkali metal cation, an ammonium group or the cation of an ammonium organic base and for n = 2 Represents alkaline earth metal cation and R ¹ and R ^{2 are} independently a hydrogen atom, an alkali or alkaline earth metal cation, an ammonium group, the cation of an ammonium organic base or a radical Z derived from a polyhydroxylated organic compound selected from the group of etherified ( C ₆ -C ₁₈ ) -alkyl polysaccharides having 1 to 6 monomeric saccharide units and / or the etherified aliphatic (C ₆ -C ₁₆ ) -hydroxyalkylpolyols having 2 to 16 hydroxyl radicals, with the proviso that at least one of the groups R ¹ or R ^{2 is} a radical Z, sulfosuccinic acid mono- and dialkyl esters having 8 to 24 C Atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethyl esters having 8 to 24 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups,

Alkyl sulfates and alkyl polyglycol ether sulfates of the formula R- (O-CH ₂ -CH ₂ ) _X -OSO ₃ H, in which R is a preferably linear alkyl group having 8 to 30 C atoms and x = 0 or 1 to 12, mixed surface-active hydroxysulfonates,

Esters of tartaric acid and citric acid with alcohols, the addition products of about 2-15 molecules of ethylene oxide and / or propylene oxide to C ₈ . _{22 are} fatty alcohols, alkyl and / or alkenyl ether phosphates, sulfated fatty acid alkylene glycol esters, monoglyceride sulfates and monoglyceride ether sulfates.

Preferred anionic surfactants and emulsifiers are acylglutamates, acyl isethionates, acyl sarcosinates and acyl taurates, each with a linear or branched acyl radical having 6 to 22 carbon atoms and 0, 1, 2 or 3 double bonds, which in particularly preferred embodiments of an octanoyl, decanoyl, lauroyl , Myristoyl, palmitoyl and stearoyl radical, esters of tartaric acid, citric acid or succinic acid or of the salts of these acids with alkylated glucose, in particular the products with the INCI name Disodium Coco-Glucoside Citrate, Sodium Coco-Glucoside Tartrate and Disodium Coco-glucosides sulfosuccinates, alkyl polyglycol ether sulfates and ether carboxylic acids having 8 to 18 carbon atoms in the alkyl group and up to 12 ethoxy groups in the molecule, sulfosuccinic acid mono- and dialkyl esters having 8 to 18 carbon atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethyl ester having 8 to 18 C Atoms in the alkyl group and 1 to 6 ethoxy groups.

Zwitterionic surfactants and emulsifiers are those surface-active compounds which carry at least one quaternary ammonium group and at least one -COO ^(- 'or -SO ₃ '^"'group in the molecule.) Particularly suitable zwitterionic surfactants and emulsifiers are the so-called betaines, such as N-alkyl-N, N-dimethylammonium glycinates, for example the cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinates, for example cocoacylaminopropyldimethylammonium glycinate, and 2-alkyl-3-carboxymethyl-3-hydroxyethylimidazolines each having 8 to 18 C -atoms in the alkyl or acyl group as well as the coconut acylaminoethylhydroxyethylcarboxymethylglycinat a preferred zwitterionic surfactant is known under the CTFA name of Cocamidopropyl Betaine ampholytic surfactants, and fatty acid amide under emulsifiers are surface-active compounds which, apart from a C ₈ -.. C ₂₄ - Alkyl or acyl group contain at least one free amino group and at least one -COOH or -SO ₃ H group and capable of forming internal salts are. Examples of suitable ampholytic surfactants are N-alkylglycines, N-alkylaminopropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C Atoms in the alkyl group. Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethyl aminopropionate and C ₂ - C ₈ - acyl sarcosine.

Nonionic surfactants and emulsifiers contain as hydrophilic group z. A polyol group, a polyalkylene glycol ether group or a combination of polyol and polyglycol ether groups. Such compounds are, for example

Addition products of 2 to 50 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear and branched fatty alcohols having 8 to 30 carbon atoms, to fatty acids having 8 to 30 carbon atoms and on

Alkylphenols having 8 to 15 C atoms in the alkyl group,

C ₂ -C ₃₀ fatty acid mono- and diesters of addition products of 1 to 30 moles of ethylene oxide

Polyols having 3 to 6 carbon atoms, in particular glycerol,

Addition products of 5 to 60 moles of ethylene oxide with castor oil and hydrogenated castor oil,

Polyol fatty (partial) ester as Hydagen ^® HSP (Cognis) or Sovermol ^® - types (Cognis), especially of saturated C. _{8 3} o-fatty acids, alkoxylated triglycerides, alkoxylated fatty acid alkyl esters,

Amine oxides,

Fatty acid alkanolamides, fatty acid N-alkylglucamides and fatty amines and their ethylene oxide or

Polyglycerol addition products,

Sorbitan fatty acid esters and adducts of ethylene oxide with sorbitan fatty acid esters such as the polysorbates,

Zuckerfettsäureester and methylglucoside fatty acid esters and their ethylene oxide or

Polyglycerol addition products,

Alkylpolyglycosides corresponding to the general formula RO- (Z) _x where R is alkyl, Z is sugar and x is the number of sugar units.

And Ci _O -alkyl groups, essentially of C ₂ - - C ₄ alkyl groups and consists essentially of C ₈ - to C ₆ -alkyl or substantially of Ci ₂ Particularly preferred alkyl polyglycosides in which R consists essentially of C ₈ - To Ci ₆ alkyl groups or consists essentially of Ci ₆ to Ci ₈ alkyl groups. As sugar building block Z it is possible to use any desired mono- or oligosaccharides. Usually, sugars with 5 or 6 carbon atoms and the corresponding oligosaccharides are used. Such sugars are, for example, glucose, fructose, galactose, arabinose, ribose, xylose, lyxose, allose, altrose, mannose, gulose, idose, talose and sucrose. Preferred sugar building blocks are glucose, fructose, galactose, arabinose and sucrose; Glucose is particularly preferred. The alkylpolyglycosides which can be used according to the invention contain on average 1, 1 to 5 sugar units. Alkyl polyglycosides having x values of 1.1 to 2.0 are preferred. Very particular preference is given to alkyl glycosides in which x is 1: 1 to 1, 8.

Mixtures of alkyl (oligo) glucosides and fatty alcohols, eg. B. Montanov ^® 68,

Sterols, e.g. Ergosterol, stigmasterol, sitosterol and mycosterols,

Phospholipids, e.g. B. lecithins or phosphatidylcholines,

Polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hydroxystearate

(Dehymuls ^® PGPH) or Triglycerindiisostearat (Lameform ^® TGI), alkoxylated polydialkylsiloxanes (INCI name: dimethicone copolyol).

Preferred nonionic surface-active substances have been the alkylpolyglycosides, optionally in admixture with fatty alcohols, alkoxylated polydialkylsiloxanes, alkylene oxide amide products of saturated linear fatty alcohols and fatty acids with 2 to 30 moles of ethylene oxide per mole of fatty alcohol or fatty acid.

Also usable according to the invention are cationic surfactants of the quaternary ammonium compound type, the esterquats and the amidoamines. Preferred quaternary ammonium compounds are ammonium halides, in particular chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides. The long alkyl chains of these surfactants preferably have 10 to 18 carbon atoms, such as. In cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride and triceptylmethylammonium chloride. Further preferred cationic surfactants are the imidazolium compounds known under the INCI names Quaternium-27 and Quaternium-83.

Are very particularly preferred composition of the invention, the addition of fatty alcohol (s) and / or fatty alcohol alkoxylate (s), preferably C _2-22 fatty alcohol (s) and / or C _2-22 fatty alcohol ethoxylate (s) having 10 to 30 EO units , particularly preferably C ₁₆ . ₁₈ fatty alcohol (s) and / or C ₁₆ . ₁₈ - fatty alcohol ethoxylate (s) having from 12 to 20 EO units, preferably in amounts of from 5 to 20% by weight, preferably from 7.5 to 17.5% by weight and in particular from 10 to 15% by weight, each based on the weight of the agent included.

Preferred hair treatment compositions according to the invention are further characterized in that they additionally contain amphoteric surfactant (s), preferably from the groups of N-alkyl,

N-alkyl propionic acids,

N-Al kylam inobutyric acids,

N-alkyliminodipropionic,

N-hydroxyethyl-N-alkylamido,

N-alkyltaurines

N-alkylsarcosines,

2-Alkylaminopropionsäuren each having about 8 to 24 carbon atoms in the alkyl group,

Alkylaminoacetic acids each having about 8 to 24 carbon atoms in the alkyl group,

N-cocoalkyl,

cocoacylaminoethylaminopropionate

C ₁₂ -C ₁₈ acylsarcosine,

N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyldimethylammoniumglycinate,

N-acylaminopropyl-N, N-dimethylammonium glycinates, for example cocoacylaminopropyl-dimethylammonium glycinate,

2-Alkyl-3-carboxymethyl-3-hydroxyethyl-imidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group

Kokosacylaminoethylhydroxyethylcarboxymethylglycinat known under the INCI name cocamidopropyl betaine compounds known under the INCI name Disodium Cocoamphodiacetate

Compounds containing preferred means the amphoteric surfactant (s) in amounts of 1 to 15% by weight, preferably from 2.5 to 12 wt .-% and in particular from 5 to 10 parts by weight. %, in each case based on the total mean.

Preferred hair treatment compositions according to the invention contain as amphoteric surfactants betaines of the formula (I)

in which R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms These surfactants are referred to the INCI nomenclature as Amidopropylbetaine, the

Representatives derived from coconut fatty acids, are preferred and are referred to as Cocoamidopropylbetaine.

Particular preference is given to using surfactants of the formula (I) within narrower ranges of amounts.

Here, agents according to the invention are preferred which, based on their weight, are from 0.25 to 8% by weight, more preferably from 0.5 to 7% by weight, more preferably from 0.75 to 6.5% by weight and in particular 1 to 5.5

% By weight of surfactant (s) of the formula (I).

In addition to the amphoteric surfactant (s) of the formula (I) or in its place, the hair-treatment compositions according to the invention may be used with particular preference as amphoteric surfactants betaines of the formula (II)

in which R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms.

These surfactants are referred to according to the INCI nomenclature as amphoacetates, wherein the representatives derived from coconut fatty acids are preferred and are referred to as cocoamphoactetates. For reasons of production technology, surfactants of this type always also contain betaines of the formula (IIa)

in which R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms and M is a cation. These surfactants are referred to according to the INCI nomenclature as Amphodiacetate, wherein the representatives derived from coconut fatty acids are preferred and are referred to as Cocoamphodiactetate.

Particular preference is given to using surfactants of the formula (II) within narrower ranges of amounts. Here, agents according to the invention are preferred which - based on their weight - 0.25 to 8 wt .-%, more preferably 0.5 to 7% by weight, more preferably 0.75 to 6.5% by weight and especially 1 to 5.5

% By weight of surfactant (s) of the formula II).

Particularly preferred nonionic surfactants are alkyl polyglycosides. Accordingly, hair treatment compositions according to the invention are preferred which contain as nonionic surfactants alkylpolyglycosides of the general formula RO- (Z) _x , where R is alkyl, Z is sugar and x is the number of

Sugar units stands.

According to the invention, preference is given to using alkylpolyglycosides corresponding to the general formula RO - (Z) _x , where R is alkyl, Z is sugar and x is the number of sugar units.

And Ci _O -alkyl groups, essentially of C ₂ - - and C ^ alkyl groups, essentially of C ₈ - to C ₆ -alkyl or substantially of Ci ₂ Particularly preferred alkyl polyglycosides in which R consists essentially of C ₈ - To Ci ₆ alkyl groups or consists essentially of Ci ₆ to Ci ₈ alkyl groups.

As sugar building block Z it is possible to use any desired mono- or oligosaccharides. Usually, sugars with 5 or 6 carbon atoms and the corresponding oligosaccharides are used. Such sugars are, for example, glucose, fructose, galactose, arabinose, ribose, xylose, lyxose, allose, altrose, mannose, gulose, idose, talose and sucrose. Preferred sugar building blocks are glucose, fructose, galactose, arabinose and sucrose; Glucose is particularly preferred. The alkylpolyglycosides which can be used according to the invention contain on average 1, 1 to 5 sugar units. Alkyl polyglycosides having x values of 1.1 to 2.0 are preferred. Very particular preference is given to alkyl glycosides in which x is 1: 1 to 1, 8.

Cationic surfactants of the quaternary ammonium compound type, the esterquats and the amidoamines can be used according to the invention. Preferred quaternary ammonium compounds are ammonium halides, in particular chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides. The long alkyl chains of these surfactants preferably have 10 to 18 carbon atoms, such as. In cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride and triceptylmethylammonium chloride. Further preferred cationic surfactants are the imidazolium compounds known under the INCI names Quaternium-27 and Quaternium-83.

Particularly preferred hair treatment compositions according to the invention are characterized in that they contain as cationic care substance - based on their weight - 0.05 to 7.5 wt .-%, preferably 0.1 to 5 wt .-%, particularly preferably 0.2 to 3, 5 wt .-% and in particular 0.25 to 2.5 wt .-% cationic (s) surfactant (s) from the group of quaternary ammonium compounds and / or the Esterquats and / or amidoamines, wherein preferred cationic surfactant (s) is / are selected

- Alkyltrimethylammoniumchloriden having preferably 10 to 18 carbon atoms in the alkyl radical and / or

- Dialkyldimethylammoniumchloride having preferably 10 to 18 carbon atoms in the alkyl radical and / or

- Trialkylmethylammoniumchloride preferably having 10 to 18 carbon atoms in the alkyl radical and / or

Cetyltrimethylammonium chloride and / or

Stearyltrimethylammonium chloride and / or

Distearyldimethylammonium chloride and / or

- Lauryldimethylammonium chloride and / or

- Lauryldimethylbenzylammoniumchlorid and / or

- tricetylmethylammonium chloride

- Quaternium-27 and / or

- Quaternium-83 and / or

- N-methyl-N (2-hydroxyethyl) -N, N- (ditalgacyloxyethyl) ammonium methosulfate and / or

- N-methyl-N (2-hydroxyethyl) -N, N- (distearoyloxyethyl) ammonium methosulfate and / or

- N, N-dimethyl-N, N-distearoyloxyethyl ammonium chloride and / or

- N, N-di (2-hydroxyethyl) -N, N- (fatty acid ethyl) ammonium chloride.

As a further optional constituent, the agents according to the invention may contain from 0.01 to 10% by weight of at least one polymer from the group of cationic and / or amphoteric polymers.

Cationic or amphoteric polymers are to be understood as meaning polymers which have a group in the main and / or side chain which may be "temporary" or "permanent" cationic. According to the invention, "permanently cationic" refers to those polymers which have a cationic group, irrespective of the pH of the agent. These are usually polymers containing a quaternary nitrogen atom, for example in the form of an ammonium group. Preferred cationic groups are quaternary ammonium groups. In particular, those polymers in which the quaternary ammonium group is bonded via a C 1-4 hydrocarbon group to a polymer main chain constructed from acrylic acid, methacrylic acid or derivatives thereof have proven to be particularly suitable.

In addition to cationic polymers or in their place, the agents according to the invention can also contain amphoteric polymers. These additionally have at least one negatively charged group in the molecule and are also referred to as zwitterionic polymers. Preferably, the polymer or polymers are used within narrower ranges. Thus, agents according to the invention are preferred which, based on their weight, are from 0.05 to 7.5% by weight, preferably from 0.1 to 5% by weight, more preferably from 0.2 to 3.5% by weight and in particular from 0.25 to 2.5% by weight of amphoteric polymer (s).

Regardless of whether the agents contain amphoteric polymers or not, further preferred agents according to the invention are characterized in that they contain, based on their weight, from 0.05 to 7.5% by weight, preferably from 0.1 to 5% by weight. -%, particularly preferably 0.2 to 3.5 wt .-% and in particular 0.25 to 2.5 wt .-% cationic (s) polymer (s) included.

Cationic polymers which can preferably be used according to the invention are described below: Homopolymers of the general formula (G1-I), R ¹

- [CH ₂ -C-] _n X ^" (G1-I)

CO-O- (CH ₂ ) _m -N ⁺ R ² R ³ R ⁴ in which R ^{1 is} -H or -CH ₃ , R ² , R ³ and R ^{4 are} independently selected from C 1-4 -alkyl , Alkenyl or -hydroxyalkyl groups, m = 1, 2, 3 or 4, n is a natural number and X ^"is a physiologically acceptable organic or inorganic anion, as well as copolymers consisting essentially of those in formula (G1 -I) In the context of these polymers, preference is given to those according to the invention for which at least one of the following conditions applies:

R ¹ is a methyl group

R ² , R ³ and R ⁴ are methyl groups m has the value 2.

Suitable physiologically tolerated counterions X ^" are, for example, halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ions, preference being given to halide ions, in particular chloride.

A particularly suitable homopolymer is, if desired, crosslinked, poly (methacryloyloxyethyltrimethylammonium chloride) with the INCI name Polyquaternium-37. Such products are available, for example under the names Rheocare ^® CTH (Cosmetic Rheologies) and Synthalen® ^® CR (Ethnichem) in trade. If desired, the crosslinking can be carried out with the aid of poly olefinically unsaturated compounds, for example divinylbenzene, tetraallyloxyethane, methylenebisacrylamide, diallyl ether, polyallylpolyglyceryl ethers, or allyl ethers of sugars or sugar derivatives such as erythritol, pentaerythritol, arabitol, mannitol, sorbitol, sucrose or glucose. Methylenebisacrylamide is a preferred crosslinking agent. The homopolymer is preferably used in the form of a nonaqueous polymer dispersion which should not have a polymer content of less than 30% by weight. Such polymer dispersions are (under the names Salcare ^® SC 95 about 50% polymer content, additional components: mineral oil (INCI name: Mineral Oil) and tridecyl-polyoxypropylene-polyoxyethylene-ether (INCI name: PPG-1 trideceth-6) ) and Salcare ^® SC 96 (about 50% polymer content, additional components: mixture of diesters of propylene glycol with a mixture of caprylic and capric acid (INCI name: propylene glycol Dicaprylate / Dicaprate) and tridecyl polyoxypropylene-polyoxyethylene-ether (INCI Designation: PPG-1-trideceth-6)) are commercially available. Copolymers with monomer units of the formula (G1-I) contain, as nonionic monomer units, preferably acrylamide, methacrylamide, acrylic acid C 1 -4 -alkyl esters and C 1 -4 -alkyl methacrylates. Among these nonionic monomers, the acrylamide is particularly preferred. These copolymers can also be crosslinked, as described above in the case of the homopolymers. A copolymer preferred according to the invention is the crosslinked acrylamide-methacryloyloxyethyltrimethylammonium chloride copolymer. Such copolymers in which the monomers are present in a weight ratio of about 20:80, are commercially available as approximately 50% non-aqueous polymer dispersion 92 under the name Salcare ^® SC. Other preferred cationic polymers are, for example, quaternized cellulose derivatives, such as are available under the names of Celquat ^® and Polymer JR ^® commercially. The compounds Celquat ^® H 100, Celquat ^® L 200 and Polymer JR ^® 400 are preferred quaternized cellulose derivatives, cationic alkyl polyglycosides according to DE-PS 44 13 686, cationized honey, for example the commercial product Honeyquat ^® 50, cationic guar derivatives, such as in particular the products sold under the trade name Cosmedia guar ^® and Jaguar ^® products, polymeric dimethyldiallylammonium salts and their copolymers with esters and amides of acrylic acid and methacrylic acid. Under the names Merquat ^® 100 (Poly (dimethyldiallylammonium chloride)) and Merquat ^® 550 (dimethyldiallylammonium chloride

Acrylamide copolymer) commercially available products are examples of such cationic polymers,

Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate, such as diethyl sulfate quaternized vinylpyrrolidone-dimethylaminoethyl methacrylate copolymers. Such compounds are sold under the names Gafquat ^® 734 and Gafquat ^® 755 commercially,

Vinylpyrrolidone vinylimidazoliummethochloride copolymers, such as those offered under the names Luviquat.RTM ^® FC 370, FC 550, FC 905 and HM 552, quaternized polyvinyl alcohol, as well as those under the names Polyquaternium 2, Polyquaternium 17, Polyquaternium 18 and

Polyquaternium 27 known polymers with quaternary nitrogen atoms in the polymer main chain.

Can be used as cationic polymers are sold under the names Polyquaternium-24 (commercial product z. B. Quatrisoft ^® LM 200), known polymers. , Gaffix ^® VC 713 (manufactured by ISP): Also according to the invention can be used the copolymers of vinylpyrrolidone, such as the commercial products Copolymer 845 (ISP manufacturer) are Gafquat ^® ASCP 1011, Gafquat ^® HS 110, Luviquat ^® 8155 and Luviquat ^® MS 370 available are.

Cationic protein hydrolysates may also be used as cationic polymers, preferred agents being one or more cationic protein hydrolyzates from the group Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Casein, Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Hair Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Rice Protein, Cocodimonium Hydroxypropyl Hydrolyzed Soy Protein, Cocodimonium Hydroxypropyl Hydrolyzed Wheat Protein, Hydroxypropyl Arginine Lauryl / Myristyl Ether HCl, Hydroxypropyltrimonium Gelatin, Hydroxypropyltrimonium Hydrolyzed Casein, Hydroxypropyltrimonium Hydrolyzed Collagen, Hydroxypropyltrimonium Hydrolyzed Conchiolin Protein, Hydroxypropyltrimonium Hydrolyzed Keratin, Hydroxypropyltrimonium Hydrolyzed Rice Bran Protein, Hydroxypropyltrimonium Hydrolyzed Soy Protein, Hydroxypropyl Hydrolyzed Vegetable Protein, Hydroxypropyltrimon Hydrolyzed Wheat Protein, Hydroxypropyltrimonium Hydrolyzed Wheat Protein / Siloxysilicate, Laurodimonium Hydroxypropyl Hydrolyzed Soy Protein, Lauridimonium Hydroxypropyl Hydrolyzed Wheat Protein, Laurodimonium Hydroxypropyl Hydrolyzed Wheat Protein / Siloxysilicate, Lauryldimonium Hydroxypropyl Hydrolyzed Casein, Lauryldimonium Hydroxypropyl Hydrolyzed Collagen, Lauryldimonium Hydroxypropyl Hydrolyzed Keratin, Lauryldimonium Hydroxypropyl Hydrolyzed Soy Protein, Steardimonium Hydroxypropyl Hydrolyzed Casein, Steardimonium Hydroxypropyl Hydrolyzed Collagen, Steardimonium Hydroxypropyl Hydrolyzed Keratin, Steardimonium Hydroxypropyl Hydrolyzed Rice Protein, Steardimonium Hydroxypropyl Hydrolyzed Soy Protein, Steardimonium Hydroxypropyl Hydrolyzed Vegetable Protein, Steardimonium Hydroxypropyl Hydrolyzed Wheat Protein, Steartrimonium Hydroxyethyl Hydrolyzed Collagen, Quaternium-76 Hydrolyzed Collagen, Quaternium-79 Hydrolyzed Collagen, Quaternium-79 Hydrolyzed Keratin, Quaternium-79 Hydrol yzed Milk Protein, Quaternium-79 Hydrolyzed Soy Protein, Quaternium-79 Hydrolyzed Wheat Protein.

In summary, hair-treatment compositions according to the invention are preferred which, based on their weight, are from 0.05 to 7.5% by weight, preferably from 0.1 to 5% by weight, particularly preferably from 0.2 to 3.5 Wt .-% and in particular 0.25 to 2.5 wt .-% cationic (s) polymer (s), containing preferred cationic (s) polymer (s) is / are selected from

Poly (methacryloyloxyethyltrimethylammonium chloride) (INCI: Polyquaternium-37) and / or; quaternized cellulose derivatives (INCI: Polyquaternium 10) and / or cationic alkylpolyglycosides and / or cationized honey and / or cationic guar derivatives and / or polymeric dimethyldiallylammonium salts and their copolymers with esters and

Amides of acrylic acid and methacrylic acid and / or

Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate and / or

Vinylpyrrolidone-Vinylimidazoliummethochlorid copolymers and / or quaternized polyvinyl alcohol and / or

Polyquaternium 2 and / or

Polyquaternium-7 and / or

Polyquaternium 17 and / or

Polyquaternium 18 and / or

Polyquaternium 24 and / or

Polyquaternium 27.

In addition to the cationic polymers or in their place, the agents of the invention may contain amphoteric polymers. In the context of the present invention preferably usable amphoteric polymers are composed essentially together

A) monomers with quaternary ammonium groups of the general formula (Z-I),

R1-CH = CR2-CO-Z- (CnH2n) -N (+) R3R4R5 A (-) (Z-I)

In the R ¹ and R ² independently of one another represent hydrogen or a methyl group and R ^3, R ⁴ and R 5 independently represent alkyl groups having 1 to 4 carbon atoms, Z is an NH group or an oxygen atom, n is an integer from 2 to 5 and A (-) is the anion of an organic or inorganic acid and

B) monomeric carboxylic acids of the general formula (Z-II),

R6-CH = CR7-COOH (Z-II) in which R6 and R7 are independently hydrogen or

Are methyl groups.

Suitable starting monomers are, for. Dimethylaminoethylacrylamide, dimethylaminoethylmethacrylamide, dimethylaminopropylacrylamide, dimethylaminopropylmethacrylamide and Diethylaminoethylacrylamide when Z is an NH group or dimethylaminoethyl acrylate,

Dimethylaminoethyl methacrylate and diethylaminoethyl acrylate when Z is an oxygen atom.

The monomers containing a tertiary amino group are then quaternized in a known manner, methyl chloride, dimethyl sulfate or diethyl sulfate being particularly suitable as alkylating reagents. The quaternization reaction can be carried out in aqueous solution or in the solvent.

Advantageously, such monomers of the formula (Z-I), the derivatives of acrylamide or

Represent methacrylamide. Preference is furthermore given to those monomers which contain halide, methoxy sulfate or ethoxy sulfate ions as counterions. Likewise preferred are those

Monomers of the formula (Z-I) in which R3, R4 and R5 are methyl groups.

The acrylamidopropyltrimethylammonium chloride is a most preferred monomer of the

Formula (Z-I).

Suitable monomeric carboxylic acids of the formula (Z-II) are acrylic acid, methacrylic acid, crotonic acid and 2-methylcrotonic acid. Preference is given to using acrylic or methacrylic acid, in particular acrylic acid.

As particularly effective, such polymers have been found in which the monomers of the

Formula (Z-I) over the monomers of formula (Z-II) were present in excess. It is therefore preferred according to the invention to use those polymers which consist of monomers of the formula (Z-I) and the monomers of the formula (Z-II) in a molar ratio of 60:40 to 95: 5, in particular of

75:25 to 95: 5, persist.

Agents preferred according to the invention are characterized in that the amphoteric (s)

Polymer (s) comprise monomers A) and B), wherein A) and B) are selected from

A) monomers with quaternary ammonium groups of the general formula (Z-I),

R1-CH = CR2-CO-Z- (CnH2n) -N (+) R3R4R5A (-) (ZI) in which R ¹ and R ² independently of one another represent hydrogen or a methyl group and R ^3, R ⁴ and R 5 independently of one another Alkyl groups having 1 to 4 carbon atoms, Z is an NH group or an oxygen atom, n is an integer of 2 to 5 and A (-) is the anion of an organic or inorganic acid, and

B) monomeric carboxylic acids of the general formula (Z-II),

R6-CH = CR7-COOH (Z-II) in which R6 and R7 are independently hydrogen or methyl groups. As a further ingredient, the agents according to the invention may with particular preference contain one or more amino acids. Particularly preferred amino acids which can be used according to the invention are from the group glycine, alanine, valine, leucine, isoleucine, phenylalanine, tyrosine, tryptophan, proline, aspartic acid, glutamic acid, asparagine, glutamine, serine, threonine, cysteine, methionine, lysine, arginine, histidine, β Alanine, 4-aminobutyric acid (GABA), betaine, L-cystine (L-Cyss), L-carnitine, L- Citrulline, L-theanine, 3 ', 4'-dihydroxy-L-phenylalanine (L-dopa), 5'-hydroxy-L-tryptophan, L-homocysteine, S-methyl-L-methionine, S-allyl-L- cysteine sulfoxide (L-alliin), L-frans-4-hydroxyproline, L -5-oxoproline (L-pyroglutamic acid), L-phosphoserine, creatine, 3-methyl-L-histidine, L-ornithine, with both the individual Amino acids and mixtures can be used. Preferred agents according to the invention contain one or more amino acids in narrower quantitative ranges. Here, preferred hair treatment compositions according to the invention are characterized in that they contain as care substance - based on their weight - 0.01 to 5 wt .-%, preferably 0.02 to 2.5 wt .-%, particularly preferably 0.05 to 1, 5 Wt .-%, more preferably 0.075 to 1 wt .-% and in particular 0.1 to 0.25 wt .-% amino acid (s), preferably from the group of glycine and / or alanine and / or valine and / or lysine and / or leucine and / or threonine. Another preferred group of ingredients of the compositions of the invention are vitamins, provitamins or vitamin precursors. These are described below:

The group of substances called vitamin A includes retinol (vitamin Ai) and 3,4-didehydroretinol (vitamin A ₂ ). The ß-carotene is the provitamin of retinol. As vitamin A component according to the invention, for example, vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as the palmitate and the acetate into consideration. The agents according to the invention preferably contain the vitamin A component in amounts of 0.05-1% by weight, based on the total preparation. The vitamin B group or the vitamin B complex includes vitamin Bi (thiamine) vitamin B ₂ (riboflavin)

Vitamin B ₃ . Under this name, the compounds nicotinic acid and nicotinamide (niacinamide) are often performed. Preferred according to the invention is the nicotinic acid amide which is contained in the agents used according to the invention preferably in amounts of from 0.05 to 1% by weight, based on the total agent.

Vitamin B ₅ (pantothenic acid, panthenol and pantolactone). Panthenol and / or pantolactone are preferably used in the context of this group. Derivatives of panthenol which can be used according to the invention are, in particular, the esters and ethers of panthenol and also cationically derivatized panthenols. Individual representatives are, for example, panthenol triacetate, panthenol monoethyl ether and its monoacetate, as well as cationic panthenol derivatives. The said compounds of the vitamin B ₅ type are preferably contained in the agents according to the invention in amounts of 0.05-10% by weight, based on the total agent. Amounts of 0.1-5 wt .-% are particularly preferred. Vitamin B ₆ (pyridoxine and pyridoxamine and pyridoxal). Vitamin C (ascorbic acid). Vitamin C is used in the agents according to the invention preferably in amounts of 0.1 to 3 wt .-%, based on the total agent. Use in the form of palmitic acid ester, glucosides or phosphates may be preferred. The use in combination with tocopherols may also be preferred.

Vitamin E (tocopherols, especially α-tocopherol). Tocopherol and its derivatives, which include in particular the esters such as the acetate, the nicotinate, the phosphate and the succinate, are preferably present in the agents according to the invention in amounts of 0.05-1% by weight, based on the total agent.

Vitamin F. The term "vitamin F" is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.

Vitamin H. Vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] imidazole-4-valeric acid, for which, however, the trivial name biotin has meanwhile prevailed. Biotin is preferably present in the compositions according to the invention in amounts of from 0.0001 to 1.0% by weight, in particular in amounts of from 0.001 to 0.01% by weight.

It has been found that the use of certain quinones enhances anti-dandruff and anti-hair loss effects as well as combability and gloss benefits. Particularly preferred hair treatment compositions according to the invention are characterized in that they contain as care substance - based on their weight - 0.0001 to 1 wt .-%, preferably 0.001 to 0.5 wt .-% and particularly preferably 0.005 to 0.1 wt .-% containing at least one ubiquinone and / or at least one ubiquinol and / or at least one derivative of these substances, preferred agents containing a ubiquinone of the formula (Ubi)

in which n stands for the values = 6, 7, 8, 9 or 10, particularly preferably 10 (coenzyme Q10). As an alternative to the particularly preferred ubiquinones or in addition to them, the agents according to the invention may also contain plastoquinones. Here, preferred agents according to the invention are characterized in that they are 0.0002 to 4 wt .-%, preferably 0.0005 to 3 wt .-%, particularly preferably 0.001 to 2 wt .-%, more preferably 0.0015 to 1 and in particular 0.002 to 0.5 wt .-% of at least one plastoquinone of the formula (Ubi-Ib)

in which n is from 1 to 20, preferably from 2 to 15 and in particular from 5, 6, 7, 8, 9, 10. To improve the elasticity and strengthen the internal structure of the hair treated with the agents according to the invention, the compositions according to the invention may contain purine and / or purine derivatives. In particular, the combination of purine and / or purine derivatives with ubiquinones and / or plastoquinones means that the hairs treated with appropriate agents show, inter alia, higher measured values in differential thermal analysis and improved wet and dry combabilities.

As a further ingredient, the agents according to the invention may therefore contain purine and / or derivative (s) of the purine. Among purine, the purines and the purine derivatives, some representatives are particularly preferred according to the invention. According to preferred hair treatment compositions according to the invention are characterized in that they contain as care substance - based on their weight - 0.001 to 2.5 wt .-%, preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt .-% and in particular from 0.01 to 0.1% by weight of purine (s) and / or purine derivative (s), the following compounds being preferred: purine, adenine, guanine, uric acid, hypoxanthine, 6-purinethiol, 6-thioguanine, xanthine , Caffeine, theobromine, theophylline.

Depending on the desired application of the compositions of the invention may vary the nature and amount of the purine derivative. Caffeine has proved particularly useful in hair cosmetic formulations, for example in shampoos preferably in amounts of from 0.005 to 0.25% by weight, more preferably from 0.01 to 0.1% by weight and in particular from 0.01 to 0, 05 wt .-% (in each case based on the shampoo) can be used.

It is also advantageous to use purine or purine derivatives and biochinones in a certain ratio to each other. Agents according to the invention are preferred in which the weight ratio of ingredients a) and b) is from 10: 1 to 1: 100, preferably from 5: 1 to 1:50, particularly preferably from 2: 1 to 1:20 and in particular from 1: 1 to 1 : 10.

As already mentioned, caffeine is a particularly preferred purine derivative, and coenzyme Q10 is a particularly preferred biochinone. Particularly preferred agents according to the invention are therefore characterized in that they contain, based on their weight, from 0.001 to 2.5% by weight, preferably from 0.0025 to 1% by weight, particularly preferably from 0.005 to 0.5% by weight and in particular 0.01 to 0.1 wt .-% caffeine and 0.0002 to 4 wt .-%, preferably 0.0005 to 3 wt .-%, particularly preferably 0.001 to 2 wt .-%, more preferably 0.0015 to 1 and in particular 0.002 to 0.5 wt .-% coenzyme Q10 included.

As a further component, the agents according to the invention may contain at least one carbohydrate from the group of monosaccharides, disaccharides and / or oligosaccharides. Here, preferred hair treatment compositions according to the invention are characterized in that they contain as care substance - based on their weight - 0.01 to 5 wt .-%, preferably 0.05 to 4.5 wt .-%, particularly preferably 0.1 to 4 wt. -%, more preferably 0.5 to 3.5 wt .-% and in particular 0.75 to 2.5 wt% carbohydrate (s) selected from monosaccharides, disaccharides and / or oligosaccharides containing preferred carbohydrates are selected out

Monosaccharides, in particular D-ribose and / or D-xylose and / or L-arabinose and / or D-glucose and / or D-mannose and / or D-galactose and / or D-fructose and / or sorbose and / or L. Fucose and / or L-rhamnose

Disaccharides, in particular sucrose and / or maltose and / or lactose and / or trehalose and / or cellobiose and / or gentiobiose and / or isomaltose. Particularly preferred agents according to the invention contain based on their weight

0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of glucose monohydrate, 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of sucrose, 0.005 to 0.015% by weight % Caffeine and 0.75-1.5% by weight fructose.

Another, more preferably usable care substance which has activating properties is taurine. According to the invention, preferred hair-treatment compositions contain as care substance - based on their weight - 0.01 to 15 wt .-%, preferably 0.025 to 12.5 wt .-%, particularly preferably 0.05 to 10 wt .-%, more preferably 0.1 to 7.5% by weight and in particular 0.5 to 5% by weight of taurine (2-aminoethanesulfonic acid).

Preference is also given to the additional use of bisabolol and / or bisabolol oxides in the agents according to the invention. Here, hair treatment compositions according to the invention are preferred which additionally contain 0.001 to 5 wt .-%, preferably 0.01 to 4 wt .-%, particularly preferably 0.02 to 2.5 wt .-% and in particular 0.1 to 1, 5 wt % Bisabolol and / or oxides of bisabolol, preferably (-) - alpha-bisabolol

contain.

The compositions of the invention may additionally contain other substances that prevent, alleviate or cure hair loss. In particular, a content of hair root stabilizing agents is advantageous.

These substances are described below:

Propecia (Finasteride) is currently the only preparation that is approved worldwide and has been proven in many studies to be effective and tolerable. Propecia causes less DHT to be produced from testosterone.

Minoxidil is probably the oldest proven with or without supplementary additives

Hair restorer. For the treatment of hair loss, it may only be used for external application. There are hair lotions containing 2% -5% minoxidil, as well as gels with up to 15% minoxidil.

The effectiveness increases with the dosage, in hair waters Minoxidil is only up to 5% share soluble. In many countries, hair tonic with up to 2% minoxidil content is available without prescription.

To combat the hormonal influences on the hair follicles spironolactone in the form of hair tonic and in combination with minoxidil can be used for external application. Spironolactone acts as an androgen receptor blocker, ie. the binding of DHT to the hair follicles is prevented.

In summary, cosmetic agents according to the invention are preferred which additionally contain, based on their weight, from 0.001 to 5% by weight of hair root stabilizing substances, in particular minoxidil and / or finasteride and / or ketoconazole.

Additional antidandruff active ingredients (for example climbazole, piroctone olamine or zinc pyrithione) are used to purposefully reduce the amount of dandruff causing the dandruff, to restore the normal bacterial count to the normal percentage and to reduce the scaling to the physiological level. However, laboratory tests have shown that the different species representatives of Pityrosporum ovale react differently to the antidandruff active ingredients. In order to combat all dandruff agents maximum is therefore a combination of anti-dandruff active ingredients most successful.

In summary, hair treatment compositions according to the invention are preferred which additionally contain, based on their weight, from 0.001 to 5% by weight of antidandruff active ingredients, in particular piroctone olamine (1-hydroxy-4-methyl-6- (2,4,4-tri-methylpentyl) -pyridine-2 ( 1 H) -one, compound with 2-aminoethanol, 1: 1) and / or zinc pyrithione and / or selenium sulfide and / or climbazole and / or salicylic acid or fumaric acid.

In a further preferred embodiment, the agents according to the invention may contain emulsifiers (F). Emulsifiers which can be used according to the invention are, for example Addition products of 4 to 30 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear fatty alcohols having 8 to 22 carbon atoms, to fatty acids having 12 to 22 carbon atoms and to alkylphenols having 8 to 15 carbon atoms in the alkyl group,

C ₂ -C ₂₂ -fatty acid mono- and diesters of addition products of from 1 to 30 mol of ethylene oxide onto polyols having from 3 to 6 carbon atoms, in particular to glycerol,

Ethylene oxide and polyglycerol addition products to methyl glucoside fatty acid esters, fatty acid alkanolamides and fatty acid glucamides,

C ₈ -C ₂₂ -alkylmono- and -oligoglycosides and their ethoxylated analogues, with on-gomerisierungsgrade of 1, 1 to 5, in particular 1, 2 to 2.0, and glucose are preferred as the sugar component,

Glucosides mixtures of alkyl (oligo) and fatty alcohols, for example, the commercially available product ^® Montanov 68,

Addition products of from 5 to 60 mol of ethylene oxide onto castor oil and hydrogenated castor oil, partial esters of polyols having 3-6 carbon atoms with saturated fatty acids having 8 to 22 carbon atoms,

Sterols. Sterols are understood to mean a group of steroids which carry a hydroxyl group on C-atom 3 of the steroid skeleton and are isolated both from animal tissue (zoosterines) and from vegetable fats (phytosterols). Examples of zoosterols are cholesterol and lanosterol. Examples of suitable phytosterols are ergosterol, stigmasterol and sitosterol. Mushrooms and yeasts are also used to isolate sterols, the so-called mycosterols. Phospholipids. Of these, especially the glucose phospholipids, e.g. as lecithins or phosphatidylcholines from e.g. Egg yolk or plant seeds (e.g., soybeans) are understood.

Fatty acid esters of sugars and sugar alcohols, such as sorbitol,

Polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hydroxystearate (commercial product Dehymuls ^® PGPH),

Linear and branched fatty acids with 8 to 30 C atoms and their Na, K, ammonium, Ca, Mg and Zn salts.

The agents according to the invention preferably contain the emulsifiers in amounts of 0.1-25% by weight, in particular 0.5-15% by weight, based on the total agent.

The compositions according to the invention may preferably comprise at least one nonionic

Emulsifier with an HLB value of 8 to 18 included. Nonionic emulsifiers with an HLB

Values of 10 to 15 may be particularly preferred according to the invention.

As further advantageous, it has been shown, if in addition to the or the polymer (s) from the

Group of cationic and / or amphoteric polymers further polymers (G) in the inventive agents are included. In a preferred embodiment, therefore, further polymers are added to the compositions according to the invention, both anionic and nonionic polymers having proven effective.

The anionic polymers (G2) are anionic polymers which have carboxylate and / or sulfonate groups. Examples of anionic monomers from which such polymers may consist are acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid. The acidic groups may be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt. Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid.

Anionic polymers which contain 2-acrylamido-2-methylpropanesulfonic acid as the sole or co-monomer can be found to be particularly effective, it being possible for all or part of the sulfonic acid group to be in the form of sodium, potassium, ammonium, mono- or triethanolammonium salt , More preferably, the homopolymer of 2-acrylamido-2-methyl propane sulfonic acid, which is available for example under the name Rheothik ^® 11-80 is commercially.

Within this embodiment, it may be preferable to use copolymers of at least one anionic monomer and at least one nonionic monomer. With regard to the anionic monomers, reference is made to the substances listed above. Preferred nonionic monomers are acrylamide, methacrylamide, acrylic esters, methacrylic esters, vinylpyrrolidone, vinyl ethers and vinyl esters.

Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with sulfonic acid-containing monomers. A particularly preferred anionic copolymer consists of 70 to 55 mol% of acrylamide and 30 to 45 mol% of 2-acrylamido-2-methylpropanesulfonic acid, wherein the sulfonic acid group is wholly or partly in the form of sodium, potassium, ammonium, mono- or triethanolammonium Salt is present. This copolymer may also be crosslinked, with crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylene-bisacrylamide are used. Such a polymer is contained in the commercial product Sepigel ^® 305 from SEPPIC. The use of this compound, which in addition to the polymer component contains a hydrocarbon mixture (Ci ₃ -Ci ₄ -lsoparaffin) and a nonionic emulsifier (laureth-7), has proved to be particularly advantageous in the context of the teaching of the invention. Also sold under the name Simulgel ^® 600 as a compound with isohexadecane and polysorbate-80 Natriumacryloyldimethyltaurat copolymers have proved to be particularly effective according to the invention.

Likewise preferred anionic homopolymers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene may be preferred Be networking agents. Such compounds are, for example, under the trademark

Carbopol ^® commercially available.

Copolymers of maleic anhydride and methyl vinyl ether, especially those with crosslinks, are also color-retaining polymers. A maleic acid cross-linked with 1, 9-decadiene

Methyl vinyl ether copolymer available under the name Stabileze® ^® QM.

In a further embodiment, the agents according to the invention can be non-ionogenic polymers

(G4).

Suitable nonionic polymers are, for example:

Vinylpyrrolidone / vinyl ester copolymers, as sold, for example, under the trademark Luviskol ^® (BASF). Luviskol ^® VA 64 and Luviskol ^® VA 73, each vinylpyrrolidone / vinyl acetate copolymers, are also preferred nonionic polymers.

Cellulose ethers such as hydroxypropyl cellulose, hydroxyethyl cellulose and hydroxypropylcellulose Methylhy-, as sold for example under the trademark Culminal® ^® and Benecel ^® (AQUALON) and Natrosol ^® grades (Hercules).

Starch and its derivatives, in particular starch, such as Structure XL ^® (National Starch), a multifunctional, salt-tolerant starch; shellac

Polyvinylpyrrolidones, as sold for example under the name Luviskol ^® (BASF).

Siloxanes. These siloxanes can be both water-soluble and water-insoluble. Both volatile and nonvolatile siloxanes are suitable, nonvolatile siloxanes being understood as meaning those compounds whose boiling point is above 200 ^° C. under normal pressure. Preferred siloxanes are polydialkylsiloxanes, such as, for example, polydimethylsiloxane, polyalkylarylsiloxanes, for example polyphenylmethylsiloxane, ethoxylated polydialkylsiloxanes and polydialkylsiloxanes which contain amine and / or hydroxyl groups. Glycosidically substituted silicones.

It is also possible according to the invention that the preparations comprise a plurality of, in particular two, different polymers of the same charge and / or in each case an ionic and an amphoteric and / or nonionic polymer.

The other polymers (G) are contained in the agents according to the invention preferably in amounts of 0.05 to 10 wt .-%, based on the total agent. Amounts of 0.1 to 5, in particular from 0.1 to 3 wt .-%, are particularly preferred.

Furthermore, in a preferred embodiment of the invention, an agent according to the invention may also contain UV filters (I). The UV filters to be used according to the invention are not subject to any general restrictions with regard to their structure and their physical properties. On the contrary, all UV filters which can be used in the cosmetics sector and whose absorption maximum lies in the UVA (315-400 nm), in the UVB (280-315 nm) or in the UVC (<280 nm) range are suitable. UV filters with an absorption maximum in the UVB range, in particular in the range from about 280 to about 300 nm, are particularly preferred.

Examples of UV filters which can be used according to the invention are 4-aminobenzoic acid, N, N, N-trimethyl-4- (2-oxoborn-3-ylidenemethyl) aniline-methylsulfate, 3,3,5-trimethyl-cyclohexylsalicylate (homosalates), 2-hydroxy-4-methoxy-benzophenone (benzophenone-3; Uvinul ^® M 40, Uvasorb MET ^{®, ®} Neo Heliopan BB, Eusolex ^® 4360), 2-phenylbenzimidazole-5-sulfonic acid and potassium, sodium and triethanolamine salts ( Phenylbenzimidazole Sulfonic Acid; Parsol ^® HS; Neo Heliopan Hydro ^®), 3,3 '- (1, 4- phenylenedimethylene) bis (7,7-dimethyl-2-oxo-bicyclo [2.2.1] hept-1- yl-methane sulfonic acid) and salts thereof, 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) Methoxydibenzoylmethane propan-1, 3-dione (butyl; Parsol ^® 1789 Eusolex ^® 9020), α - (2-oxoborn-3-ylidene) toluene-4-sulfonic acid and salts thereof, ethoxylated 4-aminobenzoic acid ethyl ester (PEG-25 PABA; Uvinul ^® P 25), 4-methylaminobenzoic acid di- 2-ethylhexyl (octyl dimethyl PABA; Uvasorb ^® DMO, Escalol ^® 507, Eusolex ^® 6007), salicylic acid-2-et hylhexyl ester (octyl salicylate; Escalol ^® 587, Neo Heliopan ^® OS, Uvinul ^® O18), 4-methoxycinnamic acid isopentyl (isoamyl p-methoxycinnamate; Neo Heliopan ^® E 1000), 4-methoxycinnamic acid 2-ethylhexyl ester (Octyl Methoxycinnamate; Parsol ^® MCX, Escalol ^® 557, Neo Heliopan AV ^®), 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its sodium salt (Benzophenone-4; Uvinul ^® MS 40; Uvasorb S 5 ^®), 3- (4'-methylbenzylidene) -D, L-camphor (4-methylbenzylidene camphor; Parsol ^® 5000, Eusolex ^® 6300), 3-benzylidene camphor (3-benzylidene camphor), 4-isopropylbenzyl, 2,4,6-trianilino- (p-carbo-2'- ethylhexyl-1'-oxi) -1, 3,5-triazine, 3-imidazol-4-yl-acrylic acid and their ethyl esters, polymers of N - {(2 and 4) - [2-oxoborn-3-ylidenemethyl] benzyl } -acrylamids, 2,4-dihydroxy (benzophenone-1; Uvasorb ^® 20 H, Uvinul ^® 400) 1, 1 '-Diphenylacrylonitrilsäure-2-ethylhexyl ester (Octocrylene; Eusolex ^® OCR, Neo Heliopan ^® Type 303, Uvinul ^® N 539 SG), o-aminobenzoic acid menthyl ester (menthyl anthranilate ; Neo Heliopan MA ^®), 2,2 ', 4,4'-tetrahydroxy benzophenone (benzophenone-2; Uvinul ^® D-50), 2,2'-dihydroxy-4,4'-dimethoxybenzophenone-5-sodium umsulfonat and 2,2'-dihydroxy-4,4'-dimethoxybenzophenone (Benzophenone-6) 2-cyano 3,3-diphenylacrylate 2'-ethylhexyl. Preference is given to 4-aminobenzoic acid, N, N, N-trimethyl-4- (2-oxoborn-3-ylidenemethyl) aniline methylsulfate, 3,3,5-trimethylcyclohexyl salicylate, 2-hydroxy-4-methoxybenzophenone , 2-phenylbenzimidazole-5-sulfonic acid and its potassium, sodium and triethanolamine salts, 3,3 '- (1, 4-phenylenedimethylene) -bis (7,7-dimethyl-2-oxo-bicyclo- [2.2.1] hept-1-yl-methanesulphonic acid) and its salts, 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) -propane-1,3-dione, α- (2-oxoboron-) 3-ylidene) -toluene-4-sulfonic acid and its salts, ethoxylated 4-aminobenzoic acid ethyl ester, 2-ethylhexyl 4-dimethylaminobenzoate, 2-ethylhexyl salicylate, isopentyl 4-methoxycinnamate, 2-ethylhexyl 4-methoxycinnamate - ester, 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its sodium salt, 3- (4'-methylbenzylidene) -D, L-camphor, 3-benzylidene-camphor, 4-isopropylbenzylsalicylate, 2,4,6- trianilino- (p-carbo-

2'-ethylhexyl-1'-oxi) -1, 3,5-triazine, 3-imidazol-4-yl-acrylic acid and their ethyl esters, polymers of N - {(2 and 4) - [2-oxoborn-3- ylidene] benzyl} acrylamide. Very particularly preferred according to the invention

2-hydroxy-4-methoxybenzophenone, 2-phenylbenzimidazole-5-sulfonic acid and its potassium, sodium and triethanolamine salts, 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) -propane-1, 3-dione, 4-methoxycinnamic acid 2-ethylhexyl ester and 3- (4'-methylbenzylidene) -D, L-camphor.

Preference is given to those UV filters whose molar extinction coefficient at the absorption maximum is above 15,000, in particular above 20,000.

According to a further embodiment of the invention, preference is given to those UV filters which have a cationic group, in particular a quaternary ammonium group.

Two preferred UV filters with cationic groups are those available as commercial products

Cinnamic acid compounds trimethylammonium chloride (lncroquat ^® UV-283) and dodecyl tosylate (Escalol ^® HP 610).

Of course, the teaching of the invention also includes the use of a combination of several UV filters. In the context of this embodiment, the combination of at least one water-insoluble UV filter with at least one UV filter with a cationic group is preferred.

The UV filters (I) are usually contained in the agents according to the invention in amounts of 0.1-5% by weight, based on the total agent. Levels of 0.4-2.5 wt .-% are preferred.

The compositions of the invention may further comprise a 2-pyrrolidinone-5-carboxylic acid and its derivatives

(J) included. The sodium, potassium, calcium, magnesium or ammonium salts in which the ammonium ion in addition to hydrogen carries one to three C _r to C ₄ alkyl groups are preferred. The

Sodium salt is most preferred. The amounts used in the inventive

Agents are preferably 0.05 to 10 wt.%, Based on the total agent, particularly preferably 0.1 to 5, and in particular 0.1 to 3 wt.%.

Finally, the compositions according to the invention may also contain plant extracts (L).

Usually these extracts are produced by extraction of the whole plant. However, it may also be preferred in individual cases, the extracts exclusively from flowers and / or leaves of

Plant to produce.

According to the invention, especially the extracts of green tea, oak bark, stinging nettle, witch hazel,

Hops, henna, chamomile, burdock root, horsetail, hawthorn, lime blossom, almond, aloe vera,

Spruce Needle, Horse Chestnut, Sandalwood, Juniper, Coconut, Mango, Apricot, Lime, Wheat,

Kiwi, Melon, Orange, Grapefruit, Sage, Rosemary, Birch, Mallow, Meadowfoam, Quendel,

Yarrow, thyme, lemon balm, toadstool, coltsfoot, marshmallow, meristem, ginseng and ginger root are preferred. Particularly preferred are the extracts of green tea, oak bark, stinging nettle, witch hazel,

Hops, chamomile, burdock root, horsetail, lime blossom, almond, aloe vera, coconut, mango,

Apricot, lime, wheat, kiwi, melon, orange, grapefruit, sage, rosemary, birch,

Meadowfoam, Quendel, Yarrow, Hauhechel, Meristem, Ginseng and Ginger root.

Especially suitable for the use according to the invention are the extracts of green tea,

Almond, aloe vera, coconut, mango, apricot, lime, wheat, kiwi and melon.

As extraction agent for the preparation of said plant extracts water, alcohols and mixtures thereof can be used. Among the alcohols are lower alcohols such as ethanol and isopropanol, but especially polyhydric alcohols such as ethylene glycol and propylene glycol, both as sole extractant and in admixture with water, are preferred. Plant extracts based on water / propylene glycol in a ratio of 1:10 to 10: 1 have proven to be particularly suitable.

The plant extracts can be used according to the invention both in pure and in diluted form. If used in dilute form, they usually contain about 2

- 80 wt .-% of active substance and as a solvent used in their extraction

Extracting agent or extractant mixture.

Furthermore, it may be preferred to use in the compositions according to the invention mixtures of several, especially two, different plant extracts.

In addition, it may prove advantageous if in the inventive compositions

Penetrants and / or swelling agents (M) are included. These include, for example, to count

Urea and urea derivatives, guanidine and its derivatives, arginine and its derivatives,

Water glass, imidazole and its derivatives, histidine and its derivatives, benzyl alcohol, glycerol,

Glycol and glycol ethers, propylene glycol and propylene glycol ethers, for example

Propylene glycol monoethyl ether, carbonates, bicarbonates, diols and triols, and in particular

1, 2-diols and 1, 3-diols such as 1, 2-propanediol, 1, 2-pentanediol, 1, 2-hexanediol, 1, 2

Dodecanediol, 1, 3-propanediol, 1, 6-hexanediol, 1, 5-pentanediol, 1, 4-butanediol.

A particularly preferred group of ingredients are the silicones.

Preferred agents according to the invention are characterized in that they contain at least one silicone, preferably a silicone, which is selected from:

(i) polyalkyl siloxanes, polyaryl siloxanes, polyalkylaryl siloxanes which are volatile or nonvolatile, straight chain, branched or cyclic, crosslinked or uncrosslinked;

(ii) polysiloxanes containing in their general structure one or more organofunctional groups selected from: a) substituted or unsubstituted aminated groups; b) (per) fluorinated groups; c) thiol groups; d) carboxylate groups; e) hydroxylated groups; f) alkoxylated groups; g) acyloxyalkyl groups; h) amphoteric groups; i) bisulfite groups; j) hydroxyacylamino groups; k) carboxy groups; I) sulfonic acid groups; and m) sulfate or thiosulfate groups;

(iii) linear polysiloxane (A) - polyoxyalkylene (B) - block copolymers of the type (AB) _n with n>3; (iv) grafted silicone polymers having a non-silicone organic backbone consisting of an organic backbone formed from organic monomers containing no silicone grafted with at least one polysiloxane macromer in the chain and optionally at least one chain end; (v) grafted polysiloxane backbone silicone polymers having grafted thereto non-silicone organic monomers having a polysiloxane backbone to which at least one organic macromer not containing silicone has been grafted in the chain, and optionally at least at one of its ends ; or their mixtures.

Particularly preferred agents according to the invention preferably comprise the silicone (s) in

Amounts of 0.1 to 10 wt .-%, preferably from 0.25 to 7 wt .-% and in particular from 0.5 to 5

Wt .-%, each based on the total agent.

Preferred silicones are described below.

Particularly preferred agents according to the invention are characterized in that they contain at least one silicone of the formula Si-I

(CH ₃ ) 3Si- [O-Si (CH ₃ ) 2] χ-O-Si (CH ₃ ) 3 (Si-I), in which x is a number from 0 to 100, preferably from 0 to 50, more preferably from 0 to 20 and especially 0 to 10, stands.

These silicones are called DIMETHICONE according to the INCI nomenclature.

Preferred according to the invention can be used silicones have viscosities at 20 ⁰ C for from 0.2 to 2 mmV ^1, wherein silicones having viscosities of 0.5 to 1 mmV ¹ are particularly preferred.

Particularly preferred agents according to the invention contain one or more amino-functional

Silicones. Such silicones may e.g. through the formula

M (R _a Q _b Si0 _{(4- a- b) / 2) x} (R _c Si0 _{(4- c) / 2) y} M wherein R in the above formula is a hydrocarbon or a hydrocarbon group of 1 to about 6 carbon atoms, Q is a polar group of the general formula -R ¹ HZ wherein R ^{1 is} a divalent linking group attached to hydrogen and the group Z is an organic, amino-functional radical containing at least one amino-functional group, carbon and hydrogen atoms, carbon, hydrogen and oxygen atoms or carbon, hydrogen and nitrogen atoms; "a" assumes values in the range of about 0 to about 2, "b" assumes values in the range of about 1 to about 3, "a" + "b" is less than or equal to 3, and "c" is a number in the range from about 1 to about 3, and x is a number ranging from 1 to about 2,000, preferably from about 3 to about 50, and most preferably from about 3 to about 25, and y is a number ranging from about 20 to about 10,000 , preferably from about 125 to about 10,000, and most preferably from about 150 to about 1,000, and M is a suitable silicone end group as known in the art, preferably trimethylsiloxy. Non-limiting examples of the groups represented by R include alkyl groups such as methyl, ethyl, propyl, isopropyl, isopropyl, butyl, isobutyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals and sulfur-containing radicals, such as mercaptoethyl, mercaptopropyl, mercaptohexyl, mercaptophenyl and the like; preferably R is an alkyl radical containing from 1 to about 6 carbon atoms, and most preferably R is methyl. Examples of R ¹ include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH ₂ CH (CH ₃ ) CH ₂ -, phenylene, naphthylene, -CH ₂ CH ₂ SCH ₂ CH ₂ -, -CH ₂ CH ₂ OCH ₂ - , -OCH ₂ CH ₂ -, -OCH ₂ CH ₂ CH ₂ -, -CH ₂ CH (CH ₃ ) C (O) OCH ₂ -, - (CH ₂ ) ₃ CC (O) OCH ₂ CH ₂ -, C ₆ H ₄ C ₆ H ₄ -, -C ₆ H ₄ CH ₂ C ₆ H ₄ -; and - (CH ₂ ) ₃ C (O) SCH ₂ CH ₂ -.

Z is an organic, amino-functional radical containing at least one functional amino group. A possible formula for Z is NH (CH ₂ ) _Z NH ₂ , wherein z is 1 or more. Another possible formula for Z is -NH (CH ₂ ) _Z (CH ₂ ) _zz NH, wherein both z and zz are independently 1 or more, this structure comprising diamino ring structures, such as piperazinyl. Z is most preferably a -NHCH ₂ CH ₂ NH ₂ radical. Another possible formula for Z is - N (CH ₂ ) _Z (CH ₂ ) _ZZ NX ₂ or -NX ₂ , wherein each X of X _{2 is} independently selected from the group consisting of hydrogen and alkyl groups of 1 to 12 carbon atoms, and zz is 0.

Q is most preferably a polar, amine functional group of the formula -CH ₂ CH ₂ CH ₂ NHCH ₂ CH ₂ NH ₂ . In the formulas, "a" assumes values in the range of about 0 to about 2, "b" assumes values in the range of about 2 to about 3, "a" + "b" is less than or equal to 3, and "c "is a number in the range of about 1 to about 3. the molar ratio of R ₃ Q _b SiO _{(4. a. b) / 2} units to the R ₀ SiO _{(4. C) / 2} units is in the range from about 1: 2 to 1:65, preferably from about 1: 5 to about 1:65, and most preferably from about 1: 15 to about 1: 20. When one or more silicones of the above formula are employed, then For example, the various variable substituents in the above formula may be different for the various silicone components present in the silicone blend. Preferred agents according to the invention are characterized in that they contain an amino-functional silicone of the formula (Si-II)

R ' _a G ₃ - _a -Si (OSiG ₂ ) _n - (OSiG _b R' ₂ - _b ) _m -O-SiG ₃ - _a -R'a (Si-II), wherein

G is -H, a phenyl group, -OH, -O-CH ₃ , -CH ₃ , -O-CH ₂ CH ₃ , -CH ₂ CH ₃ , -O-CH ₂ CH ₂ CH ₃ , -

CH ₂ CH ₂ CH ₃ , -O-CH (CH ₃ ) ₂ , -CH (CH ₃ ) ₂ , -O-CH ₂ CH ₂ CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₂ CH ₃ , -O- CH ₂ CH (CH ₃ ) ₂ , -CH ₂ CH (CH ₃ ) ₂ , -O-CH (CH ₃ ) CH ₂ CH ₃ , -CH (CH ₃ ) CH ₂ CH ₃ , -OC (CH ₃ ) ₃ , - C (CH ₃ ) ₃ ;

a is a number between O and 3, in particular O;

b is a number between 0 and 1, in particular 1,

m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n is preferably values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10,

R ^' is a monovalent radical selected from O -QN (R ") - CH ₂ -CH ₂ -N (R") ₂ o -QN (R ") ₂ O -QN ⁺ (R") ₃ A ^" o - QN ⁺ H (R ") ₂ A ^" o -QN ⁺ H ₂ (R ") A ^" o -QN (R ") - CH ₂ -CH ₂ -N ⁺ RΗ ₂ A ^" , where each Q is a chemical bond , -CH ₂ -, -CH ₂ -CH ₂ -, -CH ₂ CH ₂ CH ₂ -, -C (CH ₃ ) ₂ -, - CH ₂ CH ₂ CH ₂ CH ₂ -, -CH ₂ C (CHs) ₂ -, -CH (CH ₃ ) CH ₂ CH ₂ -,

R "is identical or different radicals from the group -H, -phenyl, -benzyl, -CH ₂ - CH (CH ₃ ) Ph, the C ^ o-alkyl radicals, preferably -CH ₃ , -CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , - CH (CH ₃ ) ₂ , -CH ₂ CH ₂ CH ₂ H ₃ , -CH ₂ CH (CH ₃ ) ₂ , -CH (CH ₃ ) CH ₂ CH ₃ , -C (CH ₃ ) ₃ , and A represents an anion, which is preferably selected from chloride, bromide, iodide or methosulfate.

Particularly preferred agents according to the invention are characterized in that they contain at least one amino-functional silicone of the formula (Si-IIa)

(CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] _n [OSi (CH ₃ )] _m -OSi (CH ₃ ) ₃ (Si-IIa),

CH ₂ CH (CH ₃ ) CH ₂ NH (CH ₂ ) ₂ NH ₂ in which m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of 0 to 1999 and in particular of 49 to 149 and m preferably values of 1 to 2000 , in particular from 1 to 10 assumes. These silicones are referred to as trimethylsilylamodimethicones according to the INCI declaration.

Also particularly preferred are agents according to the invention which are an amino-functional silicone of the formula (Si-IIb)

R- [Si (CH ₃ ) 2 -O] _n 1 [Si (R) -O] _m - [Si (CH ₃ ) 2] n 2 -R (Si-IIb), in which R is -OH, -O-CH ₃ or a -CH ₃ group and m, n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2,000, preferably between 50 and 150 , where the sum (n1 + n2) preferably assumes values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10. These silicones are referred to as amodimethicones according to the INCI declaration. Agents preferred according to the invention are characterized in that, based on their weight, they contain 0.01 to 10% by weight, preferably 0.1 to 8% by weight, particularly preferably 0.25 to 7.5% by weight and in particular 0, 5 to 5 wt.% Amino-functional silicone (s) included.

The INCI CYCLOMETHICONE designated cyclic dimethicones are inventively used with preference. Here, agents according to the invention are preferred which contain at least one silicone of the formula Si-III

in which x represents a number from 3 to 200, preferably from 3 to 10, more preferably from 3 to 7 and in particular 3, 4, 5 or 6.

Agents which are likewise preferred according to the invention are characterized in that they contain at least one silicone of the formula Si-IV

R ₃ Si [O-SiR ₂ ] χ- (CH ₂ ) _n - [O-SiR ₂ ] _y -O-SiR ₃ (Si-IV), in which R is identical or different radicals from the group H, -phenyl, -benzyl, -CH ₂ -CH (CH ₃ ) Ph, the C 1-6 -alkyl radicals, preferably -CH ₃ , -CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , CH (CH ₃ ) ₂ , -CH ₂ CH ₂ CH ₂ H ₃ , -CH ₂ CH (CH ₃ ) ₂ , -CH (CH ₃ ) CH ₂ CH ₃ , -C (CH ₃ ) ₃ , x and y represent a number from 0 to 200, preferably from 0 to 10, more preferably from 0 to 7 and especially 0, 1, 2, 3, 4, 5 or 6, and n is a number from 0 to 10, preferably from 1 to 8 and especially for 2, 3, 4, 5, 6 stands. The silicones are preferably water-soluble. Agents preferred according to the invention are characterized in that they contain at least one water-soluble silicone.

For aesthetic reasons, "clear" products are often preferred by consumers, hair treatment agents which are preferred according to the invention are therefore transparent or translucent, transparent or translucent in the context of the present invention means a composition which has an NTU value of less than or equal to 100. The NTU value (Nephelometrie Turbidity Unit) is a unit used in water treatment for turbidity measurements in liquids and is the unit of turbidity of a liquid measured with a calibrated nephelometer.

The compositions according to the invention have advantageous properties and also confer advantageous properties on the hair treated with them. Benefits have been observed especially in hair and scalp treatment. Thus, hair treatment compositions according to the invention increase the elasticity of the hair treated with them and lead to an inner-structural strengthening of the hair fibers, which is e.g. reflected in higher melting temperatures in differential thermal analysis.

There is also an improvement in wet and dry combabilities and prevention of premature splitting in the treated hair. On the skin and in particular the scalp, the compositions according to the invention cause an increase in the elasticity and, surprisingly, sebum-regulating effects. The visual impression of "greasy" skin or hair is thus avoided or weakened.

Another object of the present invention is the use of hair treatment compositions according to the invention for improving at least one of the properties

Tensile strength of keratinic fibers, especially human hair;

Grip of keratinic fibers, in particular human hair;

Combability of keratinic fibers, in particular human hair;

Gloss of keratinic fibers, especially human hair;

Color brilliance of colored hair,

Reduction in elasticity of keratinic fibers, especially human hair, when damaged by atmospheric agents.

With regard to further preferred embodiments of the use according to the invention, what has been said about the agents according to the invention applies mutatis mutandis.

Another object of the present invention is a method for the treatment of skin or hair, in which a composition according to any one of claims 1 to 15 applied to the skin and / or hair, wherein the preparation after a contact time of 0 to 45 minutes again is rinsed out. Another object of the present invention is a method for the treatment of skin or hair, in which a preparation of the invention is applied to the skin and / or hair and left there until the next wash.

With regard to further preferred embodiments of the method according to the invention, what has been said about the agents according to the invention applies mutatis mutandis.

Claims

claims: 1 . Hair treatment composition containing a) at least one quaternary imidazoline derivative having at least two long fat residues according to the formula I and Formula I, in the - The radicals R1 and R2 are each independently a saturated or unsaturated, linear or branched hydrocarbon radical having 8 to 30 carbon atoms, and - X ^{"is an} anion from the group of methosulfate, chloride, fluoride, bromide or the phosphates, b) at least one diester of ethylene glycol with two long fatty residues according to the formula II Formula II, in which the radicals R3 and R4 are each independently a saturated or unsaturated, linear or branched hydrocarbon radical having 8 to 30 Carbon atoms, and c) a cosmetic carrier. 2. Hair treatment composition according to claim 1, characterized in that it contains at least one quaternary imidazoline derivative of the formula I in which both radicals R ₁ and R ₂ are the radical - (CH ₂ ) ₂ oCH ₃ and X ^'is methosulfate. 3. Hair treatment composition according to one of claims 1 or 2, characterized in that it contains at least one diester of ethylene glycol with two long fat residues of the formula II, in which both radicals R3 and R4 are the radical - (CH ₂ ) _I7 CH ₃ . 4. hair treatment composition according to one of claims 1 to 3, characterized in that it - based on its weight - 0.1 to 5 wt .-%, preferably 0.25 to 4 wt .-%, further preferably 0.5 to 3 wt .-% and in particular 0.75 to 2 wt .-% quaternary (s) imidazoline derivative (s) having at least two long fat residues according to formula I. 5. hair treatment composition according to one of claims 1 to 4, characterized in that it - based on its weight - 0.1 to 5 wt .-%, preferably 0.25 to 4 wt .-%, more preferably 0.5 to Contains 3 wt .-% and in particular 0.75 to 2 wt .-% diester of ethylene glycol with two long fat residues according to the formula II. 6. hair treatment composition according to one of claims 1 to 5, characterized in that it - based on its weight - 0.05 to 7.5 wt .-%, preferably 0.1 to 5 wt .-%, particularly preferably 0.2 up to 3.5% by weight and in particular from 0.25 to 2.5% by weight of cationic polymer (s), preferred cationic polymer (s) being / are selected from Poly (methacryloyloxyethyltrimethylammonium chloride) (INCI: Polyquaternium-37) and / or; quaternized cellulose derivatives (INCI: Polyquaternium 10) and / or cationic alkylpolyglycosides and / or cationised honey and / or cationic guar derivatives and / or polymeric dimethyldiallylammonium salts and their copolymers with esters and Amides of acrylic acid and methacrylic acid and / or Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate and / or Vinylpyrrolidone-Vinylimidazoliummethochlorid copolymers and / or quaternized polyvinyl alcohol and / or Polyquaternium 2 and / or Polyquaternium-7 and / or Polyquaternium 17 and / or Polyquaternium 18 and / or Polyquaternium 24 and / or Polyquaternium 27. 7. hair treatment composition according to one of claims 1 to 6, characterized in that it as a care substance - based on its weight - 0.01 to 5 wt .-%, preferably 0.02 to 2.5 wt .-%, particularly preferably 0 , 05 to 1, 5 wt .-%, more preferably 0.075 to 1 wt .-% and in particular 0.1 to 0.25 wt .-% amino acid (s), preferably from the group of glycine and / or alanine and / or Valine and / or lysine and / or leucine and / or threonine. 8. hair treatment composition according to one of claims 1 to 7, characterized in that it as a care substance - based on its weight - 0.0001 to 1 wt .-%, preferably 0.001 to 0.5 wt .-% and particularly preferably 0.005 to 0 , 1 wt .-% of at least one ubiquinone and / or containing at least one ubiquinol and / or at least one derivative of these substances, preferred agents containing a ubiquinone of the formula (Ubi) in which n stands for the values = 6, 7, 8, 9 or 10, particularly preferably 10 (coenzyme Q10). 9. hair treatment composition according to one of claims 1 to 8, characterized in that it as a conditioner - based on its weight - 0.01 to 15 wt .-%, preferably 0.025 to 12.5 wt .-%, particularly preferably 0.05 to 10 wt .-%, more preferably 0.1 to 7.5 wt .-% and in particular 0.5 to 5 wt .-% taurine (2-aminoethanesulfonic acid). 10. hair treatment composition according to one of claims 1 to 9, characterized in that it additionally - based on its weight - from 0.001 to 5 wt .-% anti-dandruff agents, in particular Piroctone olamine (1-hydroxy-4-methyl-6- (2.4 , 4-trirnethylpentyl) pyridine-2 (1 H) -one, compound with 2-aminoethanol, 1: 1) and / or zinc pyrithione and / or selenium sulfide and / or climbazole and / or salicylic acid or fumaric acid. 11. Use of hair treatment composition according to any one of claims 1 to 10 for the improvement of at least one of the properties Tensile strength of keratinic fibers, especially human hair; Grip of keratinic fibers, in particular human hair; Combability of keratinic fibers, in particular human hair; Gloss of keratinic fibers, especially human hair; Color brilliance of colored hair, Reduction in elasticity of keratinic fibers, especially human hair, when damaged by atmospheric agents. 12. A method for the treatment of skin or hair, wherein a preparation according to any one of claims 1 to 10 is applied to the skin and / or the hair, wherein the preparation is rinsed out after a contact time of 0 to 45 minutes again. 13. A method for treating skin or hair, wherein a composition according to any one of claims 1 to 10 applied to the skin and / or hair and left there until the next wash.